MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,454,726 | +192890.2% | 3,201,440 | +60.1% | 7.42% | +121.5% |
| Q2 2023 | $72,260 | -2.8% | 2,000,000 | 0.0% | 3.35% | -8.3% |
| Q1 2023 | $74,360 | -99.9% | 2,000,000 | 0.0% | 3.65% | -23.5% |
| Q4 2022 | $90,620,000 | -35.1% | 2,000,000 | 0.0% | 4.78% | -39.2% |
| Q3 2022 | $139,680,000 | +4.0% | 2,000,000 | 0.0% | 7.86% | -7.6% |
| Q2 2022 | $134,260,000 | -18.4% | 2,000,000 | 0.0% | 8.50% | +0.6% |
| Q1 2022 | $164,440,000 | -43.9% | 2,000,000 | 0.0% | 8.45% | -25.8% |
| Q4 2021 | $293,380,000 | -17.1% | 2,000,000 | 0.0% | 11.39% | -7.8% |
| Q3 2021 | $353,820,000 | +9.5% | 2,000,000 | 0.0% | 12.36% | +8.4% |
| Q2 2021 | $323,060,000 | -5.7% | 2,000,000 | 0.0% | 11.40% | -1.9% |
| Q1 2021 | $342,600,000 | -11.7% | 2,000,000 | +13.3% | 11.62% | -6.8% |
| Q4 2020 | $387,788,000 | +32.3% | 1,765,560 | 0.0% | 12.46% | +23.0% |
| Q3 2020 | $293,171,000 | +45.4% | 1,765,560 | 0.0% | 10.13% | +14.3% |
| Q2 2020 | $201,574,000 | +48.5% | 1,765,560 | 0.0% | 8.86% | -4.2% |
| Q1 2020 | $135,719,000 | -38.6% | 1,765,560 | +2.9% | 9.25% | -26.0% |
| Q4 2019 | $221,067,000 | +65.4% | 1,715,560 | 0.0% | 12.50% | +29.0% |
| Q3 2019 | $133,659,000 | -24.4% | 1,715,560 | 0.0% | 9.69% | -36.2% |
| Q2 2019 | $176,703,000 | +40.5% | 1,715,560 | 0.0% | 15.19% | +4.5% |
| Q1 2019 | $125,751,000 | +89.4% | 1,715,560 | +9.6% | 14.54% | +77.2% |
| Q4 2018 | $66,411,000 | -9.9% | 1,565,560 | 0.0% | 8.20% | +0.3% |
| Q3 2018 | $73,738,000 | -4.5% | 1,565,560 | 0.0% | 8.18% | -6.4% |
| Q2 2018 | $77,182,000 | +83.2% | 1,565,560 | +14.1% | 8.74% | +94.3% |
| Q1 2018 | $42,136,000 | +68.2% | 1,372,510 | 0.0% | 4.50% | -1.7% |
| Q4 2017 | $25,048,000 | +106.2% | 1,372,510 | +32.2% | 4.58% | +65.6% |
| Q3 2017 | $12,145,000 | +220.5% | 1,037,994 | 0.0% | 2.76% | +206.9% |
| Q2 2017 | $3,789,000 | -29.8% | 1,037,994 | 0.0% | 0.90% | -23.6% |
| Q1 2017 | $5,398,000 | +49.9% | 1,037,994 | +37.0% | 1.18% | -15.3% |
| Q4 2016 | $3,600,000 | -28.1% | 757,935 | 0.0% | 1.39% | -38.0% |
| Q3 2016 | $5,010,000 | +21.1% | 757,935 | 0.0% | 2.24% | -38.8% |
| Q2 2016 | $4,138,000 | -74.5% | 757,935 | 0.0% | 3.67% | -76.9% |
| Q1 2016 | $16,220,000 | -74.6% | 757,935 | -62.5% | 15.87% | -71.2% |
| Q4 2015 | $63,934,000 | – | 2,023,232 | – | 55.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |